Life Sciences Rejuveron Increases to Near-majority Stake in Endogena Through Funding $20 Million to Progress… AIT News Desk Dec 13, 2021 Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, announced that it has strengthened its…